Made with ❤️ by True Sparrow

Bringing you the latest funding data

Outrun Therapeutics

Last funding round

Raised
$10,000,000
Round
Seed

Funding News (1)

Apr 18 2024PR Newswire

Startup details

Outrun Therapeutics

Outrun Therapeutics

Outrun Therapeutics is a biopharmaceutical company focused on unlocking the therapeutic potential of protein stabilisation by E3 ligase inhibition to treat diseases such as cancer and neurology. The company has developed a proprietary platform for rapid assessment of E3 ligase targets and is backed by leading venture capital investors.
outruntx.com
Dundee, Scotland, United Kingdom
Established in 2019
2-10 People
Healthcare, Drug Discovery and Delivery

Founders

Carolyn Porter

Carolyn Porter

Chief Executive Officer

Ex: Roche, University of California, Berkeley, MRC-PPU, The University of Dundee, National Tsing Hua University

Oxford, England, United Kingdom

Investment details

Raised
$10,000,000
Round
Seed
Investors
M Ventures
MP Healthcare Venture Management

Founder Stories

Dr. Sterghois Moschos, PulmoBioMed

Recent 5 from United Kingdom

May2024
1

Today

Bicycle raised $555M from Forbion and 6 others
UK-based Bicycle Therapeutics develops precision-guided therapeutics using 'bicycle' molecules for cancer and disease treatment.
Bicycle

Founders

Sir Gregory Winter

In News

Tech.eu
2

1 day ago

Viable raised a $3M Seed led by Martin Brailsford
London-based Viable is an Intelligent Finance platform for online and multi-channel sellers.
Viable

Founders

Henry Young,

Franklyn Martin,

Steven Haynes

In News

Silicon Canals
Tech Funding News
3

1 day ago

GreyWolf Therapeutics raised a $49.6M Series B led by ICG’s Life Sciences team
Oxfordshire-based Grey Wolf Therapeutics develops antigen modulation therapies for oncology and autoimmunity.
GreyWolf Therapeutics

Founders

Peter Joyce

In News

EU-Startups
4

2 days ago

Praktika raised a $32.5M Series A led by Blue Wire Capital
London-based Praktika delivers AI-powered language learning with personalized avatars.

Founders

Carles Reina,

Adam Turaev

In News

FinSMEs
Tech Funding News
5

3 days ago

Pheon Therapeutics raised a $120M Series B led by Research Corporation Technologies
London-based Pheon Therapeutics is an ADC specialist developing next-generation ADCs for hard-to-treat cancers.
Pheon Therapeutics

Founders

Cyrus Mozayeni

In News

FinSMEs
The pharma letter
Informazione
Spot a snag? Report it.
raised@truesparrow.com
Made with ❤️ by True Sparrow
© 2024 True Sparrow Systems Pvt. Ltd. All rights reserved.